vs
ANAPTYSBIO, INC（ANAB）与STURM RUGER & CO INC（RGR）财务数据对比。点击上方公司名可切换其他公司
STURM RUGER & CO INC的季度营收约是ANAPTYSBIO, INC的1.4倍（$151.1M vs $108.2M），ANAPTYSBIO, INC同比增速更快（151.1% vs 3.6%），ANAPTYSBIO, INC自由现金流更多（$98.0M vs $12.3M），过去两年ANAPTYSBIO, INC的营收复合增速更高（288.3% vs 5.1%）
AnaptysBio是一家处于临床阶段的生物技术企业，专注于开发适用于炎症疾病、肿瘤免疫及罕见病领域的抗体类免疫疗法，主要面向美国市场，推进创新候选药物管线研发以满足未被满足的临床需求。
鲁格公司（Ruger）是总部位于美国康涅狄格州绍斯波特的枪械制造企业，除总部外，还在新罕布什尔州纽波特、北卡罗来纳州梅约丹以及亚利桑那州普雷斯科特设有生产工厂。公司由亚历山大·麦考密克·斯特姆与威廉·B·鲁格于1949年共同创立，自1969年起公开上市交易。
ANAB vs RGR — 直观对比
营收规模更大
RGR
是对方的1.4倍
$108.2M
营收增速更快
ANAB
高出147.5%
3.6%
自由现金流更多
ANAB
多$85.7M
$12.3M
两年增速更快
ANAB
近两年复合增速
5.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $108.2M | $151.1M |
| 净利润 | $49.6M | — |
| 毛利率 | — | 17.8% |
| 营业利润率 | 61.8% | 2.3% |
| 净利率 | 45.8% | — |
| 营收同比 | 151.1% | 3.6% |
| 净利润同比 | 327.8% | — |
| 每股收益（稀释后） | $1.64 | $0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ANABRGR
| Q4 25 | $108.2M | $151.1M | ||
| Q3 25 | $76.3M | $126.8M | ||
| Q2 25 | $22.3M | $132.5M | ||
| Q1 25 | $27.8M | $135.7M | ||
| Q4 24 | $43.1M | $145.8M | ||
| Q3 24 | $30.0M | $122.3M | ||
| Q2 24 | $11.0M | $130.8M | ||
| Q1 24 | $7.2M | $136.8M |
净利润ANABRGR
| Q4 25 | $49.6M | — | ||
| Q3 25 | $15.1M | $1.6M | ||
| Q2 25 | $-38.6M | $-17.2M | ||
| Q1 25 | $-39.3M | $7.8M | ||
| Q4 24 | $-21.8M | — | ||
| Q3 24 | $-32.9M | $4.7M | ||
| Q2 24 | $-46.7M | $8.3M | ||
| Q1 24 | $-43.9M | $7.1M |
毛利率ANABRGR
| Q4 25 | — | 17.8% | ||
| Q3 25 | — | 15.1% | ||
| Q2 25 | — | 3.9% | ||
| Q1 25 | — | 22.0% | ||
| Q4 24 | — | 22.8% | ||
| Q3 24 | — | 18.5% | ||
| Q2 24 | — | 22.3% | ||
| Q1 24 | — | 21.5% |
营业利润率ANABRGR
| Q4 25 | 61.8% | 2.3% | ||
| Q3 25 | 45.5% | -2.7% | ||
| Q2 25 | -117.5% | -15.6% | ||
| Q1 25 | -99.2% | 6.2% | ||
| Q4 24 | -22.4% | 7.8% | ||
| Q3 24 | -75.8% | 3.1% | ||
| Q2 24 | -367.5% | 6.9% | ||
| Q1 24 | -587.8% | 5.5% |
净利率ANABRGR
| Q4 25 | 45.8% | — | ||
| Q3 25 | 19.8% | 1.2% | ||
| Q2 25 | -173.5% | -13.0% | ||
| Q1 25 | -141.6% | 5.7% | ||
| Q4 24 | -50.5% | — | ||
| Q3 24 | -109.4% | 3.9% | ||
| Q2 24 | -425.3% | 6.3% | ||
| Q1 24 | -612.0% | 5.2% |
每股收益（稀释后）ANABRGR
| Q4 25 | $1.64 | $0.22 | ||
| Q3 25 | $0.52 | $0.10 | ||
| Q2 25 | $-1.34 | $-1.05 | ||
| Q1 25 | $-1.28 | $0.46 | ||
| Q4 24 | $-0.63 | $0.62 | ||
| Q3 24 | $-1.14 | $0.28 | ||
| Q2 24 | $-1.71 | $0.47 | ||
| Q1 24 | $-1.64 | $0.40 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $238.2M | $92.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $37.2M | $283.8M |
| 总资产 | $364.4M | $342.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ANABRGR
| Q4 25 | $238.2M | $92.5M | ||
| Q3 25 | $109.8M | $80.8M | ||
| Q2 25 | $44.3M | $101.4M | ||
| Q1 25 | $98.6M | $108.3M | ||
| Q4 24 | $123.1M | $105.5M | ||
| Q3 24 | $191.6M | $96.0M | ||
| Q2 24 | $71.8M | $105.6M | ||
| Q1 24 | $53.7M | $115.3M |
股东权益ANABRGR
| Q4 25 | $37.2M | $283.8M | ||
| Q3 25 | $-29.4M | $279.6M | ||
| Q2 25 | $-44.7M | $289.3M | ||
| Q1 25 | $34.0M | $321.5M | ||
| Q4 24 | $70.9M | $319.6M | ||
| Q3 24 | $84.4M | $314.9M | ||
| Q2 24 | $9.9M | $321.5M | ||
| Q1 24 | $47.8M | $332.0M |
总资产ANABRGR
| Q4 25 | $364.4M | $342.0M | ||
| Q3 25 | $353.1M | $342.3M | ||
| Q2 25 | $335.3M | $349.5M | ||
| Q1 25 | $422.1M | $379.0M | ||
| Q4 24 | $483.8M | $384.0M | ||
| Q3 24 | $493.4M | $373.5M | ||
| Q2 24 | $427.4M | $376.7M | ||
| Q1 24 | $405.8M | $385.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $98.0M | $15.5M |
| 自由现金流经营现金流 - 资本支出 | $98.0M | $12.3M |
| 自由现金流率自由现金流/营收 | 90.5% | 8.2% |
| 资本支出强度资本支出/营收 | 0.0% | 2.1% |
| 现金转化率经营现金流/净利润 | 1.98× | — |
| 过去12个月自由现金流最近4个季度 | $19.6M | $38.5M |
8季度趋势，按日历期对齐
经营现金流ANABRGR
| Q4 25 | $98.0M | $15.5M | ||
| Q3 25 | $-27.4M | $12.9M | ||
| Q2 25 | $-40.2M | $14.7M | ||
| Q1 25 | $-10.7M | $11.1M | ||
| Q4 24 | $-66.7M | $20.0M | ||
| Q3 24 | $-10.1M | $9.4M | ||
| Q2 24 | $-21.3M | $18.7M | ||
| Q1 24 | $-37.3M | $7.3M |
自由现金流ANABRGR
| Q4 25 | $98.0M | $12.3M | ||
| Q3 25 | $-27.4M | $7.0M | ||
| Q2 25 | $-40.3M | $9.1M | ||
| Q1 25 | $-10.7M | $10.0M | ||
| Q4 24 | $-66.9M | $16.4M | ||
| Q3 24 | $-10.1M | $2.6M | ||
| Q2 24 | $-21.4M | $10.1M | ||
| Q1 24 | $-37.3M | $5.6M |
自由现金流率ANABRGR
| Q4 25 | 90.5% | 8.2% | ||
| Q3 25 | -35.9% | 5.5% | ||
| Q2 25 | -180.9% | 6.9% | ||
| Q1 25 | -38.7% | 7.4% | ||
| Q4 24 | -155.3% | 11.2% | ||
| Q3 24 | -33.7% | 2.1% | ||
| Q2 24 | -194.6% | 7.7% | ||
| Q1 24 | -519.3% | 4.1% |
资本支出强度ANABRGR
| Q4 25 | 0.0% | 2.1% | ||
| Q3 25 | 0.0% | 4.6% | ||
| Q2 25 | 0.2% | 4.2% | ||
| Q1 25 | 0.1% | 0.8% | ||
| Q4 24 | 0.6% | 2.5% | ||
| Q3 24 | 0.1% | 5.5% | ||
| Q2 24 | 0.3% | 6.6% | ||
| Q1 24 | 0.4% | 1.3% |
现金转化率ANABRGR
| Q4 25 | 1.98× | — | ||
| Q3 25 | -1.81× | 8.15× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.43× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.98× | ||
| Q2 24 | — | 2.27× | ||
| Q1 24 | — | 1.04× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ANAB
暂无分部数据
RGR
| Firearms | $150.6M | 100% |
| Castings | $7.3M | 5% |
